The DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
ATM Phosphorylation of Mdm2 Ser394 Regulates the Amplitude and Duration of the DNA Damage Response in Mice
Open accessAbstract
DNA damage induced by ionizing radiation activates the ATM kinase, which subsequently stabilizes and activates the p53 tumor suppressor protein. Although phosphorylation of p53 by ATM was found previously to modulate p53 levels and transcriptional activities in vivo, it does not appear to be a major regulator of p53 stability. We have utilized mice bearing altered Mdm2 alleles to demonstrate that ATM phosphorylation of Mdm2 serine 394 is required for robust p53 stabilization and activation after DNA damage. In addition, we demonstrate that dephosphorylation of Mdm2 Ser394 regulates attenuation of the p53-mediated response to DNA damage. Therefore, the phosphorylation status of Mdm2 Ser394 governs p53 protein levels and functions in cells undergoing DNA damage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By contrast, the mutation of Ser394 to alanine (Ser394Ala) in mouse MDM2 in vivo removes an ATM phosphorylation site, engenders radioresistance and increases the rate of spontaneous tumorigenesis to that observed in Trp53-hemizygous animals47.”
From MDM2, MDMX and p53 in oncogenesis and cancer therapy (2013) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Live or let die: the cell's response to p53
Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,231
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Cited by
Sorted by citations
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279
Drugging the p53 pathway: understanding the route to clinical efficacy
Khoo, K. H., Verma, C. S., & Lane, D. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4236 · Cited by 742
Regulation of the p53 response and its relationship to cancer
Meek, D. W. (2015) · Biochemical Journal · doi:10.1042/bj20150517 · Cited by 311
Chibaya, L., Karim, B. O., Zhang, H., & Jones, S. N. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2003193118 · Cited by 191
Self-citationThe ATM signaling network in development and disease
Stracker, T. H., Roig, I., Knobel, P. A., & Marjanović, M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00037 · Cited by 192
The role of ubiquitin modification in the regulation of p53
Hock, A. K., & Vousden, K. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.022 · Cited by 168
Limiting the power of p53 through the ubiquitin proteasome pathwayPreprint
Pant, V., & Lozano, G. (2014) · Genes & Development · doi:10.1101/gad.247452.114 · Cited by 170
Eischen, C. M. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026096 · Cited by 161
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
Wang, W., Albadari, N. G., Du, Y., Fowler, J. F., Sang, H. T., Xian, W., McKeon, F., Li, W., Zhou, J., & Zhang, R. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001026 · Cited by 151
Understanding p53 functions through p53 antibodies
Sabapathy, K., & Lane, D. P. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz010 · Cited by 139
Wienken, M., Dickmanns, A., Nemajerová, A., Kramer, D., Najafova, Z., Weiss, M., Karpiuk, O., Kassem, M. S., Zhang, Y., Lozano, G., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.12.008 · Cited by 116
Menon, V., & Povirk, L. F. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_17 · Cited by 105
p53/MDM2 signaling pathway in aging, senescence and tumorigenesis
Huang, Y., Che, X., Wang, P., & Qu, X. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.05.001 · Cited by 99
Pant, V., Xiong, S., Jackson, J. G., Post, S. M., Abbas, H. A., Quintás‐Cardama, A., Hamir, A. N., & Lozano, G. (2013) · Genes & Development · doi:10.1101/gad.227249.113 · Cited by 88
Yi, H., Yan, X., Luo, Q., Yuan, L., Li, B., Pan, W., Zhang, L., Chen, H., Wang, J., Zhang, Y., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0765-8 · Cited by 71
The versatile functions of ATM kinase
Xu, B., & Boohaker, R. J. (2014) · Biomedical Journal · doi:10.4103/2319-4170.125655 · Cited by 71
Li, X., Si, Y., Liang, J., Li, M., Wang, Z., Qin, Y., & Sun, L. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.05.209 · Cited by 72
Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis
Carr, M. I., & Jones, S. N. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.11.75 · Cited by 71
Self-citationMDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndrome
Li, Y., Stockton, M. E., Bhuiyan, I., Eisinger, B. E., Gao, Y., Miller, J. L., Bhattacharyya, A., & Zhao, X. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad9370 · Cited by 66
Purbey, P. K., Scumpia, P. O., Kim, P. J., Tong, A.-J., Iwamoto, K. S., McBride, W. H., & Smale, S. T. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.017 · Cited by 66
HDMX Folds the Nascent p53 mRNA following Activation by the ATM Kinase
Malbert-Colas, L., Ponnuswamy, A., Olivares‐Illana, V., Tournillon, A.-S., Naski, N., & Fåhræus, R. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.02.035 · Cited by 55
Molecular signaling cascades involved in nonmelanoma skin carcinogenesis
Feehan, R. P., & Shantz, L. M. (2016) · Biochemical Journal · doi:10.1042/bcj20160471 · Cited by 54
A single synonymous mutation determines the phosphorylation and stability of the nascent protein
Karakostis, K., Gnanasundram, S. V., López, I., Thermou, A., Wang, L., Nylander, K., Olivares‐Illana, V., & Fåhræus, R. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy049 · Cited by 54
Regulation of MDM2 Stability After DNA Damage
Li, J., & Kurokawa, M. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24994 · Cited by 49
Lane, D. P., & Verma, C. S. (2012) · Genes & Cancer · doi:10.1177/1947601912458285 · Cited by 41
Sam68 Is Required for DNA Damage Responses via Regulating Poly(ADP-ribosyl)ation
Sun, X., Fu, K., Hodgson, A., Wier, E. M., Wen, M. G., Kamenyeva, O., Xia, X., Koo, L. Y., & Wan, F. (2016) · PLoS Biology · doi:10.1371/journal.pbio.1002543 · Cited by 45
SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle
Lu, Y.-F., Xu, X.-P., Lu, X.-P., Zhu, Q., Liu, G., Bao, Y.-T., Wen, H., Li, Y.-L., Gu, W., & Zhu, W.-G. (2020) · Oncogene · doi:10.1038/s41388-020-1305-5 · Cited by 40
Structural basis for DNA damage-induced phosphoregulation of MDM2 RING domain
Magnussen, H., Ahmed, S. F., Sibbet, G. J., Hristova, V. A., Nomura, K., Hock, A. K., Archibald, L. J., Jamieson, A. G., Fushman, D., Vousden, K. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15783-y · Cited by 37
Switching on p53: an essential role for protein phosphorylation?
Loughery, J., & Meek, D. W. (2013) · Biodiscovery · doi:10.7750/biodiscovery.2013.8.1 · Cited by 39
DNA damage-induced activation of ATM promotes β-TRCP-mediated Mdm2 ubiquitination and destruction
Wang, Z. P., Inuzuka, H., Zhong, J., Fukushima, H., Wan, L., Liu, P., & Wei, W. (2012) · Oncotarget · doi:10.18632/oncotarget.640 · Cited by 39
Carr, M. I., Roderick, J. E., Gannon, H., Kelliher, M. A., & Jones, S. N. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.014 · Cited by 34
Self-citationSMG7 is a critical regulator of p53 stability and function in DNA damage stress response
Luo, H., Cowen, L. E., Yu, G., Jiang, W. G., & Tang, Y. (2016) · Cell Discovery · doi:10.1038/celldisc.2015.42 · Cited by 33
p53mRNA and p53 Protein Structures Have Evolved Independently to Interact with MDM2
Karakostis, K., Ponnuswamy, A., Fusée, L. T. S., Bailly, X., Laguerre, L., Worrall, E. G., Vojtesek, B., Nylander, K., & Fåhræus, R. (2016) · Molecular Biology and Evolution · doi:10.1093/molbev/msw012 · Cited by 35
UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation
Du, C., Wu, H., & Leng, R. P. (2015) · Oncotarget · doi:10.18632/oncotarget.6555 · Cited by 32
Targeting ATM pathway for therapeutic intervention in cancer
Khalil, H. S., Tummala, H., Chakarov, S., Zhelev, N., & Lane, D. P. (2012) · Biodiscovery · doi:10.7750/biodiscovery.2012.1.3 · Cited by 31
It Takes 15 to Tango: Making Sense of the Many Ubiquitin Ligases of p53
Love, I. M., & Grossman, S. R. (2012) · Genes & Cancer · doi:10.1177/1947601912455198 · Cited by 28
Timmerman, D. M., Remmers, T. L., Hillenius, S., & Looijenga, L. H. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105377 · Cited by 26
Medina‐Medina, I., García-Beltrán, P., la Mora, I. D. L. M.-D., Oria‐Hernández, J., Millot, G., Fåhræus, R., Reyes‐Vivas, H., Sampedro, J. G., & Olivares‐Illana, V. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00113-16 · Cited by 27
Alik, A., Bouguechtouli, C., Julien, M., Bermel, W., Ghouil, R., Zinn‐Justin, S., & Theillet, F. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202002288 · Cited by 25
ATM and ATR Activation Through Crosstalk Between DNA Damage Response Pathways
Fedak, E. A., Adler, F. R., Abegglen, L. M., & Schiffman, J. D. (2021) · Bulletin of Mathematical Biology · doi:10.1007/s11538-021-00868-6 · Cited by 29
Using Mouse Models to Explore MDM-p53 Signaling in Development, Cell Growth, and Tumorigenesis
Gannon, H., & Jones, S. N. (2012) · Genes & Cancer · doi:10.1177/1947601912455324 · Cited by 25
Self-citationDicer Cooperates with p53 to Suppress DNA Damage and Skin Carcinogenesis in Mice
Lyle, S. R., Hoover, K. L., Colpan, C., Zhu, Z., Matijašević, Z., & Jones, S. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100920 · Cited by 21
Self-citationShaping the regulation of the p53 mRNA tumour suppressor: the co-evolution of genetic signatures
Karakostis, K., & Fåhræus, R. (2019) · BMC Cancer · doi:10.1186/s12885-019-6118-y · Cited by 21
Mouse modelling of the MDM2/MDMX−p53 signalling axis
Tackmann, N. R., & Zhang, Y. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx006 · Cited by 21
MDM2 Overexpression, Activation of Signaling Networks, and Cell Proliferation
Deb, S. P., Singh, S., & Deb, S. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_12 · Cited by 18
Fu, K., Sun, X., Wier, E. M., Hodgson, A., Hobbs, R. P., & Wan, F. (2016) · eLife · doi:10.7554/elife.21957 · Cited by 17
PIAS3 promotes homology-directed repair and distal non-homologous end joining
LIU, S., Fan, Z., Geng, Z., Zhang, H., Ye, Q., Jiao, S., & Xu, X. (2013) · Oncology Letters · doi:10.3892/ol.2013.1472 · Cited by 16
What do we need to know and understand about p53 to improve its clinical value?
Salomao, N., Karakostis, K., Hupp, T., Vollrath, F., Vojtesek, B., & Fahraeus, R. (2021) · The Journal of Pathology · doi:10.1002/path.5677 · Cited by 15
Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment
Rozpędek‐Kamińska, W., Pytel, D., Nowak-Zduńczyk, A., Lewko, D., Wojtczak, R., Diehl, J. A., & Majsterek, I. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180117102233 · Cited by 15
A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo
Comiskey, D. F., Jacob, A. G., Sanford, B. L., Montes, M., Goodwin, A., Steiner, H. E., Matsa, E., Tapia-Santos, A. S., Bebee, T. W., Grieves, J. L., et al. (2017) · Oncogene · doi:10.1038/onc.2017.282 · Cited by 13
Che, J., Lu, Y., Sun, K., Feng, C., Dong, A., & Jiao, Y. (2013) · Oncology Reports · doi:10.3892/or.2013.2536 · Cited by 12
Low power lasers on genomic stability
Trajano, L. A. D. S. N., Sergio, L. P. D. S., Stumbo, A. C., Mencalha, A. L., & da Fonseca, A. D. S. (2018) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2018.02.010 · Cited by 11
Carr, M. I., Roderick, J. E., Zhang, H., Woda, B. A., Kelliher, M. A., & Jones, S. N. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611798114 · Cited by 11
Self-citationKwak, J., Choi, J., & Jang, K. L. (2017) · Oncotarget · doi:10.18632/oncotarget.20337 · Cited by 11
Considering the Role of Murine Double Minute 2 in the Cardiovascular System?
Lam, B., & Roudier, E. A. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00320 · Cited by 10
Mujoo, K., Hunt, C. R., PANDITA, R. K., Mauro Ferrari, B., Krishnan, S., Cooke, J. P., Hahn, S. M., & Pandita, T. K. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0743 · Cited by 10
E3 Ubiquitin Ligases in Cancer and Their Pharmacological Targeting
Ong, J. Y., & Torres, J. Z. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82883 · Cited by 8
Fan, Y., Fan, H., Quan, Z., & Wu, X. (2021) · Cancer Investigation · doi:10.1080/07357907.2021.1899200 · Cited by 9
Post-translational regulation enables robust p53 regulation
Shin, Y.-J., Chen, K., Sayed, A. H., Hencey, B., & Shen, X. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-83 · Cited by 9
Weak Magnetic Fields Enhance the Efficacy of Radiation Therapy
Iwamoto, K. S., Sandstrom, R. E., Bryan, M., Liu, Y., Elgart, S. R., Sheng, K., Steinberg, M. L., McBride, W. H., & Low, D. A. (2021) · Advances in Radiation Oncology · doi:10.1016/j.adro.2021.100645 · Cited by 8
Li, Y., Feng, N.-N., Zhang, G.-H., Wang, Q., Hao, Y.-H., Ya-Nanzhang, Long, C., Li, Y., Brandt‐Rauf, P. W., & Xia, Z.-L. (2013) · International Journal of Occupational Medicine and Environmental Health · doi:10.2478/s13382-013-0155-6 · Cited by 8
Alik, A., Bouguechtouli, C., Julien, M., Bermel, W., Ghouil, R., Zinn‐Justin, S., & Theillet, F. (2020) · Angewandte Chemie · doi:10.1002/ange.202002288 · Cited by 8
What a Difference a Phosphate Makes: Life or Death Decided by a Single Amino Acid in MDM2
Li, Y., & Wahl, G. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.033 · Cited by 6
Allosteric changes in HDM2 by the ATM phosphomimetic S395D mutation: implications on HDM2 function
Uhrík, L., Wang, L., Hároníková, L., Medina‐Medina, I., Rebolloso‐Gómez, Y., Chen, S., Vojtěšek, B., Fåhræus, R., Hernychová, L., & Olivares‐Illana, V. (2019) · Biochemical Journal · doi:10.1042/bcj20190687 · Cited by 6
Molecular and Biochemical Techniques for Deciphering p53-MDM2 Regulatory Mechanisms
Karakostis, K., López, I., Peña-Balderas, A. M., Fåhareus, R., & Olivares‐Illana, V. (2020) · Biomolecules · doi:10.3390/biom11010036 · Cited by 7
Intra molecular interactions in the regulation of p53 pathway
Chen, J. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.09.23 · Cited by 5
The DNA Damage Response Mediates Apoptosis and Tumor Suppression
Baran, K., Rodríguez, D. A., & Green, D. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9302-0_7 · Cited by 6
p53 regulation by ubiquitin and ubiquitin-like modifications
Wang, Y., Zhang, C., Wang, J., & Liu, J. (2022) · Genome Instability & Disease · doi:10.1007/s42764-022-00067-0 · Cited by 5
Likhatcheva, M., Gieling, R. G., Brown, J. A. L., Demonacos, C., & Williams, K. J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.720194 · Cited by 5
HDM2 and HDMX Proteins in Human Cancer
Hároníková, L., & Vojtěšek, B. (2018) · Klinicka onkologie · doi:10.14735/amko20182s63 · Cited by 4
NOTCH1 intracellular domain stabilization by MDM2 plays a major role in NSCLC response to platinum
Bernardo, S., Brunet, L. J., Thomas, Q. D., Bracquemond, D., Bouclier, C., Colomb, M., Mancini, M., Fabbrizio, E., Santos, A., Rasamizafy, S. F., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00354-9 · Cited by 3
Moraleva, A. A., Антипова, Н. В., Pavlov, P., Dobrochaeva, K. L., & Rubtsov, Y. P. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1749992 · Cited by 4
Redox signaling in development: An emerging frontier.
Ulfig, A., & Jakob, U. (2026) · Developmental Cell · doi:10.1016/j.devcel.2026.07.005 · Cited by 1
Yi, H., Han, Y., Wang, X., Li, Q., Xiong, L., & Li, S. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02049-y · Cited by 3
Koyama, M., Yamaguchi, K. D., Chigusa, Y., Yamanoi, K., Taki, M., Sunada, M., Horie, A., Hamanishi, J., Minamiguchi, S., & Mandai, M. (2023) · International Cancer Conference Journal · doi:10.1007/s13691-022-00591-6 · Cited by 2
hCINAP alleviates senescence by regulating MDM2 via p14ARF and the HDAC1/CoREST complex
Huang, X., Zhao, Y. T., Wei, M., Zhuge, R., & Zheng, X. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjad015 · Cited by 2
The Role of the DNA Damage Response in Ataxia-Telangiectasia Syndrome
Ribes‐Zamora, A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84902 · Cited by 1
Mitochondrial translocation of MDM2 and TFAM reprograms metabolism in treatment-refractory cancers
Eu, J. Q., Salleh, N. A. B. M., Hirpara, J. L., Ohi, N., Omori, E., Tan, T. Z., Seet, J. E., Hue, S. S., Chan, S. J., Lim, D. X. Y., et al. (2026) · npj Precision Oncology · doi:10.1038/s41698-025-01257-1 · Cited by 1
Puszyński, K., Jonak, K., Kurpas, M. K., Janus, P., & Szołtysek, K. (2014) · IWBBIO · Cited by 1
Dynamics of the p53 response to ionizing and ultraviolet radiationPreprint
Fedak, E. A., Adler, F. R., Young, E. L., Abegglen, L. M., & Schiffman, J. D. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/367995 · Cited by 1
Touqan, N. (2014) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Husaini, R. (2014) · Bradford Scholars (University of Bradford)
Vila, A. (2018) · DalSpace (Dalhousie University)
In Vivo Discoveries in MDM2-Mediated p53 Regulation
Tackmann, N. R. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/z7ta-7m83
Characterization of NEK10 Tyrosine Kinase Activity in the Cellular Response to DNA Damage
Haider, N. (2018) · TSpace (University of Toronto)
Effect of stress during neutron irradiation on the microstructure of type 316 stainless steel
Brager, H. R., Garner, F. A., & Guthrie, G. L. (1976) · OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information)
Scharte, J. M. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8911
3’UTR-dependent dynamic changes in TP53 mRNA localization regulate p53 tumor suppressor activityPreprint
Hu, L., Misra, S., Karim, B. O., Kuhn, S. A., Salotti, J., Basu, S., Martín, N. C. R., Saylor, K. L., & Johnson, P. F. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.04.487038
Bang, S., Bhatt, H. C., Chen, Y. Y., & Kurokawa, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-67199-4_101574
Bang, S., Bhatt, H. C., Chen, Y. Y., & Kurokawa, M. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101574-1
Non-canonical functions of the MDM2 oncoprotein
Manzini, V. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9537
Muñoz, P. A. M. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2019.tde-13032023-180307
Germ cell tumor treatment resistance and liquid biopsy-based microRNA biomarkers
Timmerman, D. M. (2024) · Utrecht University Repository (Utrecht University) · doi:10.33540/2055
Bernardo, S., Thomas, Q. D., Mancini, M., Santos, A., Rasamizafy, S. F., Maacha, A.-M., Giry, A., Bousquet, E., Papon, L., Goussard, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.29.591624
Lin, H., Ma, J., Heng, Y., Zhu, X., Jin, Q.-Y., Ding, X., Tao, L., & Lu, L. (2025) · International Journal of Cancer · doi:10.1002/ijc.35329
Bernardo, S. (2019) · theses.fr (ABES) · doi:10.70675/df87afcbz5843z4c32z9d7cz074065a8acf1
Metadata
- Authors
- Gannon, H. S., Woda, B. A., & Jones, S. N.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Jones, Stephen N.
- ORCID
- Gannon, Hugh S.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2012-05
- Volume
- 21
- Issue
- 5
- Pages
- 668-679
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3360886
- OpenAlex
- W2117932700
- Cited by
- 105
- References
- 48
- Citations by year
- 2026: 7 · 2025: 1 · 2024: 5 · 2023: 3 · 2022: 4 · 2021: 9 · 2020: 7 · 2019: 9 · 2018: 10 · 2017: 5 · 2016: 13 · 2015: 4 · 2014: 11 · 2013: 10 · 2012: 6
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 442 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (CA077735)
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- ATM kinase, MDM2, p53 stabilization, DNA damage response, ionizing radiation, p53 activation
- MeSH terms
- Animals, DNA Damage, DNA-Binding Proteins, Enzyme Activation, Intestine, Small, Mice, Inbred C57BL, Phosphorylation, Radiation Tolerance, Serine, Spleen, Thymus Gland, Time Factors, Tumor Suppressor Protein p53, Apoptosis, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Mutation, Missense, Tumor Suppressor Proteins, Mice, Proto-Oncogene Proteins c-mdm2, Protein Stability, Mice, 129 Strain, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review